Alyeska Investment Group, L.P. Natera, Inc. Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $2.81 Million - $4.45 Million	-100,000 Reduced 38.46%	160,000 $5.67 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $3.52 Million - $10.6 Million	116,191 Added 80.8%	260,000 $10.6 Million
Q4 2020 Feb 16, 2021	SELL	$66.66 - $111.74 $3.52 Million - $5.91 Million	-52,869 Reduced 26.88%	143,809 $14.3 Million
Q3 2020 Nov 16, 2020	SELL	$45.89 - $72.67 $5.91 Million - $9.35 Million	-128,711 Reduced 39.56%	196,678 $14.2 Million
Q2 2020 Aug 14, 2020	BUY	$26.36 - $49.86 $6.77 Million - $12.8 Million	256,977 Added 375.63%	325,389 $16.2 Million
Q1 2020 May 15, 2020	SELL	$17.27 - $40.17 $688,002 - $1.6 Million	-39,838 Reduced 36.8%	68,412 $2.04 Million
Q4 2019 Feb 14, 2020	BUY	$32.1 - $40.4 $3.47 Million - $4.37 Million	108,250 New	108,250 $3.65 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.